Showing results (111-120 of 141) with videos related to
Sort By:
Pageof 15
The Journal of Neuropsychiatry and Clinical Neurosciences|April 21, 1998
The clinician-scientist in neuropsychiatry: a position statement from the Committee on Research of the American Neuropsychiatric AssociationJ L Cummings, C E Coffey, J D Duffy, et al.Journal of Medicinal Chemistry|September 11, 2018
Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling BiasNicole M Kennedy, Cullen L Schmid, Nicolette C Ross, et al.General Hospital Psychiatry|April 21, 2026
Evaluating the potential risk of ketamine-induced hepatotoxicity in the treatment of mood and anxiety disorders: A systematic reviewGabrielle F M Lovell, Shreya Vasudeva, Diana K Orsini, et al.Journal of Clinical Pathology|January 30, 2004
Recipes for adult stem cell plasticity: fusion cuisine or readymade?M R Alison, R Poulsom, W R Otto, et al.Analytical Methods : Advancing Methods and Applications|January 14, 2014
LC-MS/MS quantification of salvinorin A from biological fluidsMichael J Caspers, Todd D Williams, Kimberly M Lovell, et al.Journal of Medicinal Chemistry|May 1, 1981
1-Aryl-3-azabicyclo[3.1.0]hexanes, a new series of nonnarcotic analgesic agentsJ W Epstein, H J Brabander, W J Fanshawe, et al.Breast Cancer Research and Treatment|March 27, 2012
The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapyP Di Giovanni, T S Ahearn, S I K Semple, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|August 26, 1998
Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric AssociationE C Lauterbach, J L Cummings, J Duffy, et al.The Biochemical Journal|July 21, 2010
Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitorsNyssa Drinkwater, Hoan Vu, Kimberly M Lovell, et al.Medchemcomm|March 24, 2012
Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin AKatherine M Prevatt-Smith, Kimberly M Lovell, Denise S Simpson, et al.Pageof 15